Kimia Farma AGM approves appointment of new commissioner
Jakarta (ANTARA) - The state-owned pharmaceutical company PT Kimia Farma (Persero) Tbk (KAEF) has approved the addition of a new member to its Board of Commissioners, Bonanza Perwira Taihitu, during its Annual General Meeting of Shareholders (AGM). Additionally, shareholders approved the honourable dismissal of Jasmine Karsono as Director of Portfolio, Products, and Services.
KAEF President Director Djagad Prakasa Dwialam stated during a public presentation in Jakarta on Wednesday that the changes to the management structure are part of a strategic move to strengthen corporate governance, support business transformation, and enhance the implementation of long-term strategies.
“The shareholders are encouraging management to strengthen business fundamentals. The various decisions agreed upon during the AGM are part of strategic efforts to support the strengthening of governance, increase operational effectiveness, and improve the company’s overall performance,” said Djagad.
He expressed confidence that these steps would further strengthen the organisation’s capacity to execute its transformation agenda and improve sustainable performance. He also extended gratitude to the outgoing management for their commitment and contributions to KAEF.
He continued that this move reaffirms the commitment to continuously apply Good Corporate Governance (GCG) principles to strengthen business fundamentals and maintain business sustainability amidst evolving industry dynamics and economic challenges.
Following the AGM decisions, the KAEF management structure is as follows:
Board of Commissioners:
President Commissioner and Independent Commissioner: Stefan Looho
Independent Commissioner: Diah Kusumawardani
Independent Commissioner: Fachmi Idris
Commissioner: Suprianto
Commissioner: Sumarjati Arjoso
Commissioner: Bonanza Perwira Taihitu
Board of Directors:
President Director: Djagad Prakasa Dwialam
Director of Finance and Risk Management: Willy Meridian
Director of Production and Supply Chain: Hadi Kardoko
Director of Human Resources: Disril Revolin Putra
Commercial Director: Hanadi Setiarto
Bonanza Perwira Taihitu has served as an Expert Staff member in the field of Politics & Global Health at the Ministry of Health since 2025. He previously served as the Head of the Centre for Global Health Policy and Health Technology at the Ministry of Health from 2022 to 2024, and as the Political Function II Coordinator for Health Cooperation, Human Rights, and Humanitarian Affairs at the Ministry of Foreign Affairs in 2019. His educational background includes a Bachelor’s in International Relations from Airlangga University (1998) and a Master’s in Political Science from the University of Indonesia (2003).
In the first quarter of 2026, Kimia Farma recorded a net profit growth of 197.79 per cent year-on-year (yoy) to Rp123.6 billion, ending a trend of annual losses and providing a solid foundation to achieve optimistic full-year targets.
“This achievement in Q1 2026 is not just a number, but evidence that the transformative steps we are taking are starting to bear fruit. We are committed to continuous improvement to ensure Kimia Farma returns to being the pride of the national health industry,” said Djagad.
Source: jawawa.id (https://jawawa.id/newsitem/kimia-farma-agm-approves-appointment-of-new-commissioner-1780836164)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5593297/rupst-kimia-farma-setujui-angkat-komisaris-baru), translated from Indonesian